CTOs on the Move

MegaMex Foods

www.megamexfoods.com

 
MegaMex Foods, LLC. engages in marketing, selling, and supplying Mexican food products and ingredients in the United States.
  • Number of Employees: 25-100
  • Annual Revenue: $100-250 Million

Executives

Name Title Contact Details

Similar Companies

Bobbie

European style organic infant formula that meets the U.S. FDAs nutritional requirements. Bobbie is the only female-founded and mom-led infant formula company in the U.S.

JUST

JUST is a food technology company with a mission is to build a food system where everyone has access to delicious, nutritious food. Our technology, which is based upon understanding plants from every corner of the planet, enables consumers, food manufacturers, and the largest retailers around the world to offer better, healthier products, at a more affordable cost.

Nemco Food Equipment

A manufacturer of innovative Food Prep and Food Warming equipment offering the industry`s most complete line of manually operated countertop equipment. No knockoffs or half-baked ideas. Just hardworking, innovative foodservice products that we design, engineer, and manufacture to perform better for you.

S-Ventures PLC

S Ventures PLC is a company that invests in and acquires exciting brands in the natural and organic consumer space, building a platform for growth across brand, distribution, and manufacturing.

Neptune Technologies and Bioressources

Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.